Investors

Financial Information

한미약품의 경영지표를 확인하실 수 있습니다.

Summarized Income Statement

(1 million won , K-IFRS)
Quarterly and yearly information
Category 2020 2019 2018 2017 2016
Sales revenue 1,075,854 1,113,650 1,015,962 916,586 882,725
Cost of sales 494,935 481,167 475,047 398,182 421,869
Gross profit 580,918 632,482 540,916 518,404 460,856
Selling general administrative expenses 319,555 334,316 291,436 284,952 291,189
Ordinary development costs 212,387 194,288 165,906 151,289 142,894
Operating Income (Loss) 48,976 103,878 83,574 82,164 26,772
Finance income 4,380 11,552 6,863 5,117 8,473
Finance cost 32,656 25,877 25,068 10,700 10,459
Other income 14,740 10,843 8,563 9,350 47,170
Other expenses 13,310 17,126 23,578 27,081 63,958
Profit (loss) before tax 22,130 83,270 50,355 58,850 7,998
Income tax expense 4,841 19,402 16,199 (10,124) (22,302)
Profit (loss) 17,290 63,867 34,156 68,974 30,300
Other comprehensive income 3,398 (21,284) (6,288) (4,616) (13,043)
Total comprehensive income 20,688 42,583 27,868 64,357 17,256